PRESS RELEASE
3 June 2025

Jaime Choi And Mike Orlando Named 2025 Leaders Of Influence In Life Sciences

SM
Sheppard Mullin Richter & Hampton

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
Partners Jaime Choi and Mike Orlando were named to the San Diego Business Journal’s 2025 “Leaders of Influence in Life Sciences."
United States

Partners Jaime Choi and Mike Orlando were named to the San Diego Business Journal’s 2025 “Leaders of Influence in Life Sciences." This annual list recognizes 50 influential leaders in the life sciences industry.

Choi, a partner in the Intellectual Property practice group and member of the Life Sciences industry team, was recognized for patenting complex, interdisciplinary technologies and helping her clients build and strategically enforce patent portfolios. This is her third consecutive year on this list.

Orlando, a partner in the firm’s Life Sciences team and co-leader of the Technology Transactions team, was selected for advising life sciences, healthcare and technology clients on developing, commercializing and procuring technology through strategic transactions for over 20 years. Recently, he represented Tharimmune in an exclusive license with Intract Pharma for a chimeric monoclonal antibody and drug delivery platform to develop oral products to treat various autoimmune diseases.

See the full list here.

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More